Skip to main content
Caplight Logo









M2i Life Sciences

M2i Life Sciences

Private
Saint-CloudHealthcare & Life Scienceshttps://m2i-lifesciences.com/

Last Round

VC Round

Sep 3, 2019

Total Funding Raised

$13.44M

Company Overview

M2i Life Sciences is an agricultural chemicals company that manufactures biocontrol products intended for agricultural ecological transition.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clean Manufacturing, Drug Discovery, Sustainable Materials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

pheromone-based biocontrolbiopesticidesinsect pheromonescrop protectionmating disruptionagtechinsecticide alternativesustainable agriculturecontract development and manufacturingCDMOmicro-encapsulationbiomimicrycustom synthesiscontract research organizationCROanimal health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

M2i Life Sciences Comparables

Compare M2i Life Sciences with similar companies based on industry and business-model similarity.

M2i Life Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Provivi
84%
SEDQ Healthy Crops
83%
Russell IPM Ltd.
80%

M2i Life Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundSep 3, 2019
Series AJun 26, 2017

M2i Life Sciences Investors

Notable investors and investment history

M2i Life Sciences investors
InvestorRounds
Idinvest PartnersSeries A
Téthys InvestVC Round
CreadevVC Round
ADM CapitalVC Round
Eurazeo GrowthVC Round
Groupe RAISEVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 22, 2026

    Monthly visitors increased 33% MoM, reaching 1.1K.

  • Nov 28, 2024

    Monthly visitors grew 36% MoM, from 557 to 760.

M2i Life Sciences Filings

Explore SEC and related filing metadata, where available.

M2i Life Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about M2i Life Sciences's valuation, stock price, and market status.

Is M2i Life Sciences a public or private company?

M2i Life Sciences is a private company.

What is the current stock price of M2i Life Sciences?

M2i Life Sciences is a private company with no public stock price. No recent secondary market data is available.

How much is M2i Life Sciences worth (valuation)?

Valuation information for M2i Life Sciences is not publicly available.

Can I buy M2i Life Sciences stock?

M2i Life Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was M2i Life Sciences's last funding round?

M2i Life Sciences's most recent funding round was VC Round on September 3, 2019.

Who are the main investors in M2i Life Sciences?

Key investors in M2i Life Sciences include Idinvest Partners, ADM Capital.

Will M2i Life Sciences IPO soon?

No public IPO plans have been announced for M2i Life Sciences.

How can I track M2i Life Sciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor M2i Life Sciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSaint-Cloud
Employee Range91
Year Founded2012
Last FundingSep 3, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?